Why Is Eli Lilly (LLY) Stock Soaring Today What Happened? Shares of global pharmaceutical company Eli Lilly (
NYSE:LLY ) jumped 6.3% in the afternoon session after the European Medicines Agency's commit...
Snap’s Specs Gamble The smartphone could be a thing of the past if Snap has its way. But at $2,195, it could be a tall order to sell Specs to consumers, even if they were stylish.
Fidelity (FHLC) vs. iShares (IXJ): Which Healthcare ETF Delivers Better Value? Compare global reach to domestic focus as these two funds reveal key differences in cost, risk, and portfolio makeup for healthcare investors.
Small-Cap ProQR Therapeutics Secures Funding From Eli Lilly On Early Trial Success ProQR reported positive AX-0810 Phase 1 data and raised $50 million, with Eli Lilly joining a concurrent share purchase.
Nancy Pelosi Stock Tracker Flags Eli Lilly, Nokia After Trump Praise: ‘Keep An Eye On These Two’ Nancy Pelosi Stock Tracker told investors to "keep an eye" on Eli Lilly and Nokia after Trump praised the companies in Pennsylvania.
The Artificial Intelligence Opportunity Beyond Big Tech: 3 Healthcare Stocks to Watch These companies' innovative qualities could help them get ahead of their peers in capitalizing on AI.
Why Illumina (ILMN) Stock Is Trading Up Today What Happened? Shares of genomics company Illumina (
NASDAQ:ILMN ) jumped 6.6% in the morning session after it appointed a high-profile Eli Lilly executive to ...
Eli Lilly, Abbisko Expand Drug Hunt With $1.9 Billion Research Pact Abbisko Therapeutics signed a new Eli Lilly partnership worth up to $1.9 billion to develop novel medicines globally.
1 Mid-Cap Stock to Own for Decades and 2 We Question Mid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large addressable markets. But the man...
Sangamo Bankruptcy Puts Gene Therapy Platforms In Play, Eli Lilly And Astellas Circle Sangamo files for Chapter 11 as Eli Lilly and Astellas step in to buy its valuable gene therapy and genome-editing assets.
Eli Lilly vs Viking Therapeutics: Which GLP-1 Stock Is the Better Buy? The GLP-1 drug market is massive and still growing fast. Investing in a promising growth stock in the space could lead to significant returns.
3 Monster Stocks to Hold for the Next 10 Years These healthcare stocks may be the building blocks of a winning portfolio.
2 Underrated Weight Loss Stocks to Buy and Hold They look well-positioned to grab a slice of the fast-growing anti-obesity market.
Branded Pharmaceuticals Stocks Q1 Teardown: Supernus Pharmaceuticals (NASDAQ:SUPN) Vs The Rest As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the branded pharmaceuticals industry, incl...
Why This Mid-Cap Biotech Could Be the Dark-Horse Threat to Eli Lilly and Novo Nordisk Viking Therapeutics aspires to take market share from both Eli Lilly and Novo Nordisk, and it might succeed.
13 Stocks Are Members of the $1 Trillion Club. Here's the Best Pick to Buy Right Now. Want to really go big? One megacap stock offers an especially attractive risk-reward proposition.
